Premium
Calcium influx pathways in breast cancer: opportunities for pharmacological intervention
Author(s) -
Azimi I,
RobertsThomson S J,
Monteith G R
Publication year - 2014
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/bph.12486
Subject(s) - breast cancer , regulator , calcium , cancer , calcium signaling , cancer research , cancer cell , cell growth , biology , chemistry , medicine , microbiology and biotechnology , neuroscience , biochemistry , gene
Ca 2+ influx through Ca 2+ permeable ion channels is a key trigger and regulator of a diverse set of cellular events, such as neurotransmitter release and muscle contraction. Ca 2+ influx is also a regulator of processes relevant to cancer, including cellular proliferation and migration. This review focuses on calcium influx in breast cancer cells as well as the potential for pharmacological modulators of specific Ca 2+ influx channels to represent future agents for breast cancer therapy. Altered expression of specific calcium permeable ion channels is present in some breast cancers. In some cases, such changes can be related to breast cancer subtype and even prognosis. In vitro and in vivo models have now helped identify specific Ca 2+ channels that play important roles in the proliferation and invasiveness of breast cancer cells. However, some aspects of our understanding of Ca 2+ influx in breast cancer still require further study. These include identifying the mechanisms responsible for altered expression and the most effective therapeutic strategy to target breast cancer cells through specific Ca 2+ channels. The role of Ca 2+ influx in processes beyond breast cancer cell proliferation and migration should become the focus of studies in the next decade.